Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JMS CoTSE:7702 55 FCF Yield % is -9.60 as of Sep. 17, 2026. GuruFocus rates TSE:7702 with a GF Score™ of 55/100 and a GF Value™ of 円509.13 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 849 Medical Devices & Instruments companies, JMS Co ranks worse than 72.56% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, JMS Co's Trailing 12-Month Free Cash Flow is 円-892 Mil, and Market Cap is 円11,186 Mil. Therefore, JMS Co's FCF Yield % for today is -9.60%.
The historical rank and industry rank for JMS Co's FCF Yield % or its related term are showing as below:
TSE:7702'
s FCF Yield % Range Over the Past 10 Years
Min: -9.69 Med: 0 Max: 0
Current: -9.6
TSE:7702's FCF Yield % is ranked worse than 72.56% of 849
companies
in the Medical Devices & Instruments industry
Industry Median: -0.36
vs TSE:7702: -9.60
JMS Co's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
JMS Co FCF Yield % Related Terms
JMS Co FCF Yield % Historical Data
* Premium members only.
The historical data trend for JMS Co's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7702 vs ISRG, BDX, RMD: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, JMS Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMS Co FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMS Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where JMS Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMS Co (TSE:7702) has a FCF Yield % of -9.60 as of Sep. 17, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on JMS Co and its competitors. According to the industry distribution chart, JMS Co ranks #616 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 72.6%.
Is JMS Co's FCF Yield % too high?
JMS Co's current FCF Yield % is -9.60. Based on the distribution chart, JMS Co ranks #616 out of 849 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, JMS Co has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JMS Co's FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JMS Co ranks #616 out of 849 companies for FCF Yield %. This places JMS Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on JMS Co and its competitors. JMS Co's current FCF Yield % is -9.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMS Co stock overvalued right now?
Based on GuruFocus' analysis, JMS Co (TSE:7702) is currently considered Modestly Undervalued. The stock's GF Value™ is 円509.13, compared to a current price of 円456.00 — trading 10.4% below its estimated fair value. The current FCF Yield % is -9.60. JMS Co's overall GF Score™ is 55/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For JMS Co (TSE:7702), the current FCF Yield % is -9.60 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMS Co (TSE:7702) Overvalued in 2026?
Based on GuruFocus' analysis, JMS Co stock appears to be undervalued.
The current stock price of 円456.00 is trading 10.4% below its estimated GF Value™ of 円509.13.
GuruFocus considers JMS Co to be Modestly Undervalued.
Key valuation signals for TSE:7702:
FCF Yield %: -9.60
GF Value™: 円509.13 vs. price of 円456.00 (10.4% below fair value)
No single metric tells the full story. See the TSE:7702 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMS Co Ltd is a Japan-based medical equipment manufacturer. The company is engaged in the manufacture, sale, export, and import of medical equipment and pharmaceuticals. Products offered by the company include an infusion pump, syringe pump, surgical gown, peritoneal dialysate, dialyzer, mask cap, sheet for treatment, pacemaker, heat exchanger, blood bag, among others. JMS has network operations in various countries including Europe, North America, Asia, the Middle East, Latin America and Africa.
55GF Score
Get the complete analysis for TSE:7702
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7702 has been successfully added to your 
